|
|
|
«
1-A
B
C-D
E-G
H-L
M
N-O
P
Q-R
S
T-U
V-Z
»
|
 |
|
|
Pacific Venture Group
Offices: Encino-Irvine, California
Pacific Venture Group serves as the lead
investor in early and expansion-stage companies
with high growth and profit potential across
all segments of healthcare. Their venture
capital professionals are committed to using
their experience and contacts in concert
with Management to build successful companies
which are leaders in their industry. The
firm currently manages two venture funds
whose limited partners include pension funds,
financial institutions, and healthcare companies. |
Pappas Ventures
Offices: Durham-Research Triangle, North
Carolina
At Pappas Ventures, their sole focus is
investing in the life sciences—biotechnology,
specialty pharmaceuticals, drug delivery,
medical devices and related ventures. their
success, however, is not simply a product
of investment capital. They bring experience,
creativity and passion to each and every
partnership. And in so doing, they’re bringing
promising technologies to commercial application—from
concept to commerce. |
Pearl Street Venture Funds
Offices: Indianapolis, Indiana; Gaithersburg,
Maryland & Los Angeles, California
Pearl Street Venture Funds’ strategy is
to invest in therapeutic product companies
that develop and integrate the “next generation”
of technologies. These companies would ideally
fill the pipelines of large pharmaceutical
companies with drugs that have the potential
to treat the underlying causes of important
human diseases. |
Pittsburgh Life Sciences Greenhouse (PLSG)
Offices: Pittsburgh, Pennsylvania
The Pittsburgh Life Sciences Greenhouse
was created specifically to build on Pittsburgh's
strengths in the Life Sciences enabling
the region to become a premier national
and international center in their targeted
areas. By helping researchers and entrepreneurs
get their ideas and discoveries into the
marketplace, PLSG will help build the critical
mass of Life Sciences organizations necessary
to improve the regional economy and quality
of life. |
POSCO BioVentures
Offices: Carlsbad, California
POSCO BioVentures is a venture capital fund
dedicated solely to biotechnology investments.
POSCO BioVentures has only one limited partner,
POSCO, the $20 billion Korean steel company
through its American subsidiary POSAM. POSCO
has made a strategic decision to diversify,
and the first step in its diversification
strategy is focused on building a biotechnology
business. Investments are made across all
stages of early company development and
in a variety of disciplines, including therapeutics,
diagnostics, platform technologies, and
non-life science companies. |
|
|
Prolog Ventures
Offices: St Louis, Missouri
Prolog is a venture capital firm with approximately
$100 million under management specializing
in life sciences and related information
technologies. Prolog invests in companies
that pursue solutions in life sciences,
health care, and related information technologies.
They are proud of their portfolio companies,
and they are committed to helping them achieve
wise growth and long-term success. Prolog's
value is enhanced by their team members'
long-standing connections with many other
venture capital firms, to whom they can
turn for syndication of larger investment
rounds. |
ProQuest Investments
Offices: Princeton, New Jersey & San
Diego, California
ProQuest is a healthcare venture capital
firm with over $350 million under management.
They invest in healthcare companies seeking
seed to late-stage financing. Their portfolio
reflects the rich diversity of the healthcare
industry and exemplifies their commitment
to fostering the growth of exceptional businesses.
In addition to their breadth of experience
across many sectors of the healthcare industry,
they have special expertise in therapeutics,
where innovations in drug discovery technologies
and molecular analysis are transforming
an enormous unmet medical need and offering
great commercial opportunities to build
value. |
Prospect Venture Partners
Offices: Palo Alto, California
Prospect Venture Partners has $600M of capital
under management. The firm is dedicated
to investing in outstanding biomedical technology
and life science companies. Prospect targets
commercially attractive health care enterprises
with outstanding entrepreneurial management
teams, proprietary products, and innovative
technology or services with potential for
significant investment returns. The firm
invests in companies with a broad range
of development and financing requirements
including: (a) incubating new companies,
(b) investing in first and second venture
financing rounds, and (c) participating
in later stage private and public companies
with proven business models requiring expansion
capital. |
Psilos Group
Offices: New York, New York
Founded in 1998, Psilos Group is a venture
capital firm specializing in investments
in companies in the healthcare sector. With
over $230 million under management, the
firm applies the significant entrepreneurial,
operating and investment experience of their
principals and advisory board members to
help their portfolio companies establish
themselves in the market and build their
long-term growth potential. The company
is currently investing from its Psilos II
fund, with a focus on revenue stage and
later stage companies. |
PTV Sciences
Offices: Houston, Texas
PTV Sciences was founded in 2003 to invest
in seed and early stage growth opportunities
in life and material sciences. Much like
the untapped reserves which created the
modern day oil and gas industry in 1901,
the Texas region and the Southern US has
a wealth of untapped resources in its academic
institutions and research centers. The Firm
has the benefit of the direct experience
and infrastructure support of the principals,
who over the last century have been investing
in and building sustainable, successful
companies in energy, financial services,
agriculture and real estate. |
Puretech Ventures
Offices: Boston, Massachusetts
Puretech specializes in seed and early-stage
investment in novel therapeutics, medical
devices, and research technologies. They
focus on major unmet medical needs that
have yet to be addressed by emerging science.
Enlisting the world’s leading academic and
industry experts, they identify novel technologies
(often prior to publication) and create
companies that drive those discoveries to
commercially and clinically driven milestones. |
| |
|
|
|
|
|
Bio
Life (-Quaker-)
Resources
to
top